General Information

We are a global medical technology company focused on developing and commercializing innovative and proprietary orthobiologic products for the treatment of patients suffering from a broad array of musculoskeletal conditions. Our products address the growing need for clinically effective, cost efficient and minimally invasive solutions that enhance the body’s natural healing processes. We operate our business through four reportable segments: Active Healing Therapies—U.S., Active Healing Therapies—International, Surgical and BMP.

Employees: 650
Founded: 2011
Contact Information
Address 4721 Emperor Boulevard, Suite 100, Durham, NC 27703, US
Phone Number (919) 474-6700
Web Address
View Prospectus: Bioventus
Financial Information
Market Cap $566.1mil
Revenues $265.7 mil (last 12 months)
Net Income $-23.3 mil (last 12 months)
IPO Profile
Symbol BIOV
Exchange NASDAQ
Shares (millions): 8.8
Price range $16.00 - $18.00
Est. $ Volume $150.0 mil
Manager / Joint Managers J.P. Morgan/ Piper Jaffray
CO-Managers Stifel/ Leerink Partners
Expected To Trade: 7/29/2016
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change